234 related articles for article (PubMed ID: 19897215)
1. Effects of diterpenes from latex of Euphorbia lactea and Euphorbia laurifolia on human immunodeficiency virus type 1 reactivation.
Avila L; Perez M; Sanchez-Duffhues G; Hernández-Galán R; Muñoz E; Cabezas F; Quiñones W; Torres F; Echeverri F
Phytochemistry; 2010 Feb; 71(2-3):243-8. PubMed ID: 19897215
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes.
Redel L; Le Douce V; Cherrier T; Marban C; Janossy A; Aunis D; Van Lint C; Rohr O; Schwartz C
J Leukoc Biol; 2010 Apr; 87(4):575-88. PubMed ID: 19801499
[TBL] [Abstract][Full Text] [Related]
3. Identification, structural modification, and dichotomous effects on human immunodeficiency virus type 1 (HIV-1) replication of ingenane esters from Euphorbia kansui.
Liu Q; Li W; Huang L; Asada Y; Morris-Natschke SL; Chen CH; Lee KH; Koike K
Eur J Med Chem; 2018 Aug; 156():618-627. PubMed ID: 30031972
[TBL] [Abstract][Full Text] [Related]
4. Isolation of new phenylacetylingol derivatives that reactivate HIV-1 latency and a novel spirotriterpenoid from Euphorbia officinarum latex.
Daoubi M; Marquez N; Mazoir N; Benharref A; Hernández-Galán R; Muñoz E; Collado IG
Bioorg Med Chem; 2007 Jul; 15(13):4577-84. PubMed ID: 17481906
[TBL] [Abstract][Full Text] [Related]
5. Dual effects of the novel ingenol derivatives on the acute and latent HIV-1 infections.
Yang H; Li X; Yang X; Lu P; Wang Y; Jiang Z; Pan H; Zhao L; Zhu Y; Khan IU; Shen Y; Lu H; Zhang T; Jiang G; Ma Z; Wu H; Zhu H
Antiviral Res; 2019 Sep; 169():104555. PubMed ID: 31295520
[TBL] [Abstract][Full Text] [Related]
6. SJ23B, a jatrophane diterpene activates classical PKCs and displays strong activity against HIV in vitro.
Bedoya LM; Márquez N; Martínez N; Gutiérrez-Eisman S; Alvarez A; Calzado MA; Rojas JM; Appendino G; Muñoz E; Alcamí J
Biochem Pharmacol; 2009 Mar; 77(6):965-78. PubMed ID: 19100719
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicities and anti-herpes simplex virus activities of diterpenes isolated from Euphorbia species.
Mucsi I; Molnár J; Hohmann J; Rédei D
Planta Med; 2001 Oct; 67(7):672-4. PubMed ID: 11582549
[TBL] [Abstract][Full Text] [Related]
8. HIV reservoirs, latency, and reactivation: prospects for eradication.
Dahl V; Josefsson L; Palmer S
Antiviral Res; 2010 Jan; 85(1):286-94. PubMed ID: 19808057
[TBL] [Abstract][Full Text] [Related]
9. Reactivation of latent HIV-1 in vitro using an ethanolic extract from Euphorbia umbellata (Euphorbiaceae) latex.
Valadão ALC; Pezzuto P; Silva VAO; Gonçalves BS; Rossi ÁD; da Cunha RD; Siani AC; Tostes JBF; Trovó M; Damasco P; Gonçalves G; Reis RM; Aguiar RS; Bento CAM; Tanuri A
PLoS One; 2018; 13(11):e0207664. PubMed ID: 30481211
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of phorbol-13-monoesters on human immunodeficiency virus reactivation.
Márquez N; Calzado MA; Sánchez-Duffhues G; Pérez M; Minassi A; Pagani A; Appendino G; Diaz L; Muñoz-Fernández MA; Muñoz E
Biochem Pharmacol; 2008 Mar; 75(6):1370-80. PubMed ID: 18241838
[TBL] [Abstract][Full Text] [Related]
11. In vitro reactivation of human immunodeficiency virus 1 from latently infected, resting CD4+ T cells after bacterial stimulation.
Moriuchi H; Moriuchi M; Mizell SB; Ehler LA; Fauci AS
J Infect Dis; 2000 Jun; 181(6):2041-4. PubMed ID: 10837189
[TBL] [Abstract][Full Text] [Related]
12. Reactivation of HIV-1 from Latency by an Ingenol Derivative from Euphorbia Kansui.
Wang P; Lu P; Qu X; Shen Y; Zeng H; Zhu X; Zhu Y; Li X; Wu H; Xu J; Lu H; Ma Z; Zhu H
Sci Rep; 2017 Aug; 7(1):9451. PubMed ID: 28842560
[TBL] [Abstract][Full Text] [Related]
13. Prostratin as a new therapeutic agent targeting HIV viral reservoirs.
Hezareh M
Drug News Perspect; 2005 Oct; 18(8):496-500. PubMed ID: 16391719
[TBL] [Abstract][Full Text] [Related]
14. Reservoirs of human immunodeficiency virus type 1: the main obstacles to viral eradication.
Pomerantz RJ
Clin Infect Dis; 2002 Jan; 34(1):91-7. PubMed ID: 11731950
[TBL] [Abstract][Full Text] [Related]
15. Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection.
Blankson JN; Finzi D; Pierson TC; Sabundayo BP; Chadwick K; Margolick JB; Quinn TC; Siliciano RF
J Infect Dis; 2000 Dec; 182(6):1636-42. PubMed ID: 11069234
[TBL] [Abstract][Full Text] [Related]
16. Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4(+) T Cells from Aviremic Patients.
Spivak AM; Bosque A; Balch AH; Smyth D; Martins L; Planelles V
Antimicrob Agents Chemother; 2015 Oct; 59(10):5984-91. PubMed ID: 26169416
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms involved in HIV-1 transcriptional latency and reactivation: implications for the development of therapeutic strategies.
Van Lint C; Quivy V; Demonté D; Chariot A; Vanhulle C; de Walque S; Gaudray G; Veithen E; Bours V; Piette J; Burny A
Bull Mem Acad R Med Belg; 2004; 159(Pt 2):176-89. PubMed ID: 15615091
[TBL] [Abstract][Full Text] [Related]
18. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes.
Huang J; Wang F; Argyris E; Chen K; Liang Z; Tian H; Huang W; Squires K; Verlinghieri G; Zhang H
Nat Med; 2007 Oct; 13(10):1241-7. PubMed ID: 17906637
[TBL] [Abstract][Full Text] [Related]
19. A new cytotoxic casbane diterpene from Euphorbia pekinensis.
Liang QL; Dai CC; Jiang JH; Tang YP; Duan JA
Fitoterapia; 2009 Dec; 80(8):514-6. PubMed ID: 19560525
[TBL] [Abstract][Full Text] [Related]
20. 4-Deoxyphorbol inhibits HIV-1 infection in synergism with antiretroviral drugs and reactivates viral reservoirs through PKC/MEK activation synergizing with vorinostat.
De la Torre-Tarazona HE; Jiménez R; Bueno P; Camarero S; Román L; Fernández-García JL; Beltrán M; Nothias LF; Cachet X; Paolini J; Litaudon M; Alcami J; Bedoya LM
Biochem Pharmacol; 2020 Jul; 177():113937. PubMed ID: 32224142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
